Swiss medicines authority issues first approval for antimalarial drug for treatment of infants

Switzerland's aesculapian products authorization has granted the archetypal support for a malaria medicine designed for tiny infants, touted arsenic an beforehand against a illness that takes hundreds of thousands of lives - astir each successful Africa - each year.